Abstract：Refeeding syndrome generally refers to the electrolyte metabolism disorder characterized by hypophosphatemia after the
body re-ingestion of nutrients after a long period of hunger or malnutrition which adversely affects the heart liver respiratory system
nervous system and muscular system leading to clinical complications and even death. For severely malnourished patients refeeding
syndrome is a potentially fatal complication. The incidence of refeeding syndrome among hospitalized patients in different hospitals
ranges from 0. 43% to 34% and among tumor patients receiving nutritional treatment the incidence of refeeding syndrome can be as
high as about 25%. The pathogenesis pathological and physiological changes of refeeding syndrome are related to insulin resistance
electrolyte transfer to cells and enhanced synthetic metabolism. Based on existing research and evidence combined with clinical
experience this article summarizes and recommends the diagnosis and treatment of tumor patients with refeeding syndrome.
中国抗癌协会肿瘤营养专业委员会,中华医学会肠外肠内营养学分会. 肿瘤患者再喂养综合征专家共识[J]. 肿瘤代谢与营养电子杂志, 2023, 10(5): 616-618.
Chinese Society of Nutritional Oncology, Chinese Society for Parenteral and Enteral Nutrition. Expert consensus on refeeding syndrome in cancer patients. Electron J Metab Nutr Cancer, 2023, 10(5): 616-618.
